Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation

Pennsylvania and Connecticut Labs Both Receive Accreditation PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has...
April 23, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New York State Approval

State of New York Approves Commercialization of ThyraMIR® Now in Three Specimens PARSIPPANY, NJ, April 23, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today...
April 02, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica

Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
March 19, 2019 16:05 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results

Business Progress and Recent Accomplishments Highlighted and Discussed Further on Conference Call PARSIPPANY, NJ, March 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:...
March 04, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company

PARSIPPANY, NJ, March 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”) announced today that the Pittsburgh Business Times has designated Interpace...
February 28, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Preliminary 2018 Revenues

Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
February 19, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®

PARSIPPANY, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that BMJ Open Gastroenterology, an on-line, peer-reviewed, open access...
February 04, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

PARSIPPANY, NJ, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced the Company will attend the 21st BIO CEO & Investor Conference being held in New...
January 29, 2019 16:20 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced...
January 25, 2019 06:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the pricing of an underwritten public offering of...